Arif Kamal: Know your Prostate Specific Antigen score
Arif Kamal shared a post on LinkedIn:
“Know your score.
As guidelines recommend shared decision making between clinicians and those with a prostate, it’s critical that the information necessary to make that decision is known. In the case of prostate cancer, that information is the Prostate Specific Antigen (PSA) score.
While mortality of the vast majority of cancers is going down, prostate cancer is soberingly unique. More advanced cancers, and mortality, going in the wrong direction. Trends which reflect that decreased PSA testing at the national level around a decade ago are catching up with us.
Appreciate the partnership with National Basketball Association (NBA) Hall of Famer Alonzo Mourning who has partnered with your American Cancer Society to “block” prostate cancer with the same fervor as he did for some many record-setting years on the hardwood.”
Source: Arif Kamal/LinkedIn
Arif Kamal is the first-ever Chief Patient Officer for the American Cancer Society and drives efforts to advance cancer care. With experience at Duke University and the Duke Cancer Institute, he is an Associate Professor of Medicine and Population Health. He is also a Co-Founder of Prepped Health. Dr. Kamal’s expertise lies in oncology quality assessment, palliative care, and innovative technology solutions for patient engagement.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023